FDA Inspection 1284770 — Heartland Center For Reproductive Medicine, PC
The FDA completed an inspection of Heartland Center For Reproductive Medicine, PC on Sep 29, 2025 in Omaha, NE. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 29, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Omaha, NE (United States)